Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts

Cellular Immunology

Volumn 264, Issue 1, 2010, Pages 104-109

  Into, T ^a   Inomata, M ^a   Shibata, K ^b   Murakami, Y ^a  

^a ASAHI UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antimicrobial peptide; Gingival fibroblasts; Innate immunity; Lipopolysaccharide; LL 37; Toll like receptor

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B ALPHA; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GINGIVAL FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CELLS, CULTURED; CHEMOKINE CXCL10; FIBROBLASTS; GENE EXPRESSION REGULATION; GINGIVA; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-6; INTERLEUKIN-8; LIGANDS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTAL DISEASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 77954144593     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.05.005     Document Type: Article

References (45)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Midwood K., Sacre S., Piccinini A.M., Inglis J., Trebaul A., Chan E., Drexler S., Sofat N., Kashiwagi M., Orend G., Brennan F., Foxwell B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 2009, 15:774-780.
3. Brodsky I., Medzhitov R. Two modes of ligand recognition by TLRs. Cell 2007, 130:979-981.
4. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
5. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
6. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
7. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001, 413:732-738.
8. Liu L., Botos I., Wang Y., Leonard J.N., Shiloach J., Segal D.M., Davies D.R. Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science 2008, 320:379-381.
9. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
10. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 2009, 388:621-625.
11. Mahanonda R., Sa-Ard-Iam N., Montreekachon P., Pimkhaokham A., Yongvanichit K., Fukuda M.M., Pichyangkul S. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J. Immunol. 2007, 178:1151-1157.
12. Ara T., Kurata K., Hirai K., Uchihashi T., Uematsu T., Imamura Y., Furusawa K., Kurihara S., Wang P.L. Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J. Periodontal Res. 2009, 44:21-27.
13. Gutierrez-Venegas G., Kawasaki-Cardenas P., Cruz-Arroyo S.R., Perez-Garzon M., Maldonado-Frias S. Actinobacillus actinomycetemcomitans lipopolysaccharide stimulates the phosphorylation of p44 and p42 MAP kinases through CD14 and TLR-4 receptor activation in human gingival fibroblasts. Life Sci. 2006, 78:2577-2583.
14. Shimabukuro Y., Murakami S., Okada H. Antigen-presenting-cell function of interferon γ-treated human gingival fibroblasts. J. Periodontal Res. 1996, 31:217-228.
15. Takashiba S., Takigawa M., Takahashi K., Myokai F., Nishimura F., Chihara T., Kurihara H., Nomura Y., Murayama Y. Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1β or tumor necrosis factor α. Infect. Immun. 1992, 60:5253-5258.
16. Wang P.L., Ohura K., Fujii T., Oido-Mori M., Kowashi Y., Kikuchi M., Suetsugu Y., Tanaka J. DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. Biochem. Biophys. Res. Commun. 2003, 305:970-973.
17. Durr U.H., Sudheendra U.S., Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 2006, 1758:1408-1425.
18. De Smet K., Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett. 2005, 27:1337-1347.
19. Rosenfeld Y., Papo N., Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 2006, 281:1636-1643.
20. Nijnik A., Pistolic J., Wyatt A., Tam S., Hancock R.E. Human cathelicidin peptide LL-37 modulates the effects of IFN-γ on APCs. J. Immunol. 2009, 183:5788-5798.
21. Mookherjee N., Brown K.L., Bowdish D.M., Doria S., Falsafi R., Hokamp K., Roche F.M., Mu R., Doho G.H., Pistolic J., Powers J.P., Bryan J., Brinkman F.S., Hancock R.E. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 2006, 176:2455-2464.
22. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 2000, 192:1069-1074.
23. Elssner A., Duncan M., Gavrilin M., Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 2004, 172:4987-4994.
24. Braff M.H., Hawkins M.A., Di Nardo A., Lopez-Garcia B., Howell M.D., Wong C., Lin K., Streib J.E., Dorschner R., Leung D.Y., Gallo R.L. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 2005, 174:4271-4278.
25. Puklo M., Guentsch A., Hiemstra P.S., Eick S., Potempa J. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol. Immunol. 2008, 23:328-335.
26. Lee S.H., Jun H.K., Lee H.R., Chung C.P., Choi B.K. Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int. J. Antimicrob. Agents 2010, 35:138-145.
27. Turkoglu O., Emingil G., Kutukculer N., Atilla G. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J. Periodontol. 2009, 80:969-976.
28. Into T., Inomata M., Nakashima M., Shibata K., Hacker H., Matsushita K. Regulation of MyD88-dependent signaling events by S-nitrosylation retards Toll-like receptor signal transduction and initiation of acute-phase immune responses. Mol. Cell. Biol. 2008, 28:1338-1347.
29. Into T., Kanno Y., Dohkan J., Nakashima M., Inomata M., Shibata K., Lowenstein C.J., Matsushita K. Pathogen recognition by Toll-like receptor 2 activates Weibel-Palade body exocytosis in human aortic endothelial cells. J. Biol. Chem. 2007, 282:8134-8141.
30. Shibata K., Hasebe A., Into T., Yamada M., Watanabe T. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts. J. Immunol. 2000, 165:6538-6544.
31. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
32. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003, 301:640-643.
33. Bowdish D.M., Davidson D.J., Speert D.P., Hancock R.E. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 2004, 172:3758-3765.
34. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
35. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 2003, 4:1144-1150.
36. Jerala R. Structural biology of the LPS recognition. Int. J. Med. Microbiol. 2007, 297:353-363.
37. Hiraoka T., Izumi Y., Sueda T. Immunochemical detection of CD14 on human gingival fibroblasts in vitro. Oral Microbiol. Immunol. 1998, 13:246-252.
38. Lee H.K., Dunzendorfer S., Soldau K., Tobias P.S. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 2006, 24:153-163.
39. Schroder N.W., Heine H., Alexander C., Manukyan M., Eckert J., Hamann L., Gobel U.B., Schumann R.R. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 2004, 173:2683-2691.
40. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., Beutler B. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
41. Into T., Fujita M., Okusawa T., Hasebe A., Morita M., Shibata K. Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages. Infect. Immun. 2002, 70:3586-3591.
42. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Kent R.L. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 1998, 25:134-144.
43. Haffajee A.D., Cugini M.A., Tanner A., Pollack R.P., Smith C., Kent R.L., Socransky S.S. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J. Clin. Periodontol. 1998, 25:346-353.
44. Ji S., Hyun J., Park E., Lee B.L., Kim K.K., Choi Y. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J. Periodontal Res. 2007, 42:410-419.
45. Asai Y., Hashimoto M., Fletcher H.M., Miyake K., Akira S., Ogawa T. Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling. Infect. Immun. 2005, 73:2157-2163.